Ribosome-Inactivating Proteins and Leishmania: New Strategies for Future Research
Few drugs are under investigation for the cure of leishmaniasis and none has so far proved to be totally satisfactory. Researchers are therefore still looking for new substances which could be employed as an-tileishmanial agents. We now draw attention to a group of proteins extracted from plants and known as ribosome-inactivating proteins (RIPs) which have recently given great interest for their wide potential uses in chemotherapy (1–5).
KeywordsCutaneous Leishmaniasis Acanthamoeba Castellanii Pokeweed Antiviral Protein Leishmania Promastigotes Antileishmanial Drug
Unable to display preview. Download preview PDF.
- 1.S. Olnes and A. Phil, Toxic lectins and related proteins, in: ‘Molecular action of toxins and viruses’, P. Cohen and S. van Heyningen, eds., Elsevier, Amsterdam, New York (1982).Google Scholar
- 2.L. Barbieri and F. Stirpe, Ribosome-inactivating proteins from plants: properties and possible uses, Cancer Surveys 1: 489 (1982).Google Scholar
- 11.L. Barbieri, C. Stoppa and A. Bolognesi, Large scale chromatographic purification of ribosome-inactivating proteins, J. Chromat.(in the press).Google Scholar
- 12.E.S. Vitella and J.W. Uhr, Immunotoxins, Ann.Rev.Lnnunol.3: 197 (1985).Google Scholar
- 16.C.L. Villemez, M.A. Russell. L. Barbieri, F. Stirpe, J.D. Irvin and J.D. Robertus, Catalytic toxins for the preparation of protozoan irnmunotoxins, in: ‘Membrane-mediated cytotoxicity’, B. Bonavida and R.J. Collier, eds., Alan R. Liss, New York (1987).Google Scholar